In some cancer types, the MAPK- and/or PI3K/Akt-dependent radio-resistance and/or chemo-resistance has been reported to be promoted by RKIP reduction, via constitutive phosphorylation and activation of ERK and/or Akt [34,200,201,202]. This evidence concerns the gene AKT1 and cancer.